NSC |
Compound |
Enrichment |
Correlation |
NSC 716678 |
Null |
0.00182957917645007 |
0.036280169 |
NSC 716688 |
Null |
0.00182957917645007 |
-0.32720641 |
NSC 722985 |
Null |
0.00182957917645007 |
0.31634139 |
NSC 724780 |
(1S,4R,5R,12R,13S)-9-[(2-{[(1S,4R,5R,8R,12R,13S)-1,5-dimethy l)-11,14,15,16-tetraoxatetracyclo[10.3.1.04,13.08,13]hexadec -9-en-9-yl]methoxy}ethoxy)methyl]-1,5-dimethyl-10-(trifluoro methyl)-11,14,15 |
0.00182957917645007 |
0.54754545 |
NSC 113497 |
16,17-Seco-24-nor-5.alpha.,13.alpha.,14.beta.,17.alpha.-chola-1,20,22-trien-16-oic acid, 14,15.beta.:21,23-diepoxy-7.alpha.,17-dihydroxy-4,4,8-trimethyl-3-oxo-, 16,17-lactone, acetate (8CI) |
0.00216534295403404 |
0.27698826 |
NSC 13151 |
Null |
0.00216534295403404 |
0.44390926 |
NSC 173552 |
L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate |
0.00216534295403404 |
0.30191661 |
NSC 185065 |
Hydrazinecarbothioamide, 2-[(5-hydroxy-2-pyridinyl)methylene]-N-(3-pyridinyl)- |
0.00216534295403404 |
0.1767634 |
NSC 371777 |
Null |
0.00216534295403404 |
0.17801767 |
NSC 685827 |
Null |
0.00216534295403404 |
0.24899833 |